![Immunology / Ipilimumab / Melanoma / Immunotherapy / Targeted therapy / CTLA-4 / Oncology / Management of cancer / Tremelimumab / Medicine / Bristol-Myers Squibb / Cancer treatments Immunology / Ipilimumab / Melanoma / Immunotherapy / Targeted therapy / CTLA-4 / Oncology / Management of cancer / Tremelimumab / Medicine / Bristol-Myers Squibb / Cancer treatments](https://www.pdfsearch.io/img/d55b1cdca275a4bb59fcb479627d6bd4.jpg) Date: 2015-05-09 06:46:30Immunology Ipilimumab Melanoma Immunotherapy Targeted therapy CTLA-4 Oncology Management of cancer Tremelimumab Medicine Bristol-Myers Squibb Cancer treatments | | Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration MD Anderson News ReleaseBristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center toAdd to Reading ListSource URL: www.mdanderson.orgDownload Document from Source Website File Size: 218,59 KBShare Document on Facebook
|